Skip to main content
. 2021 Sep 1;11:641453. doi: 10.3389/fonc.2021.641453

Table 1.

Correlation of Rictor expression with clinicopathological characteristics in 92 gastric cancer patients.

Factors Cases Rictor
n (%) P value
Gender
Male 57 44(81.5) 0.238
Female 35 27(77.1)
Age(yr)
≤60 30 22(68.8) 0.470
>60 62 49(79.0)
Location
Upper 11 10(90.9) 0.173
Central 24 18(75.0)
Lower 49 36(73.5)
Diffuse 8 7(87.5)
Size
<5cm 41 35(85.4) 0.019*
≥5cm 51 35(68.3)
Depth of invasion
TI+T2 14 13(92.9) 0.026*
T3+T4 78 58(74.4)
Lymph node metastasis
Negative 23 18(78.2) 0.037*
Positive 69 53(76.8)
Distant metastasis
M0 84 64(76.2) 0.033*
M1 8 7(87.5)
TNM stage
I 9 9(100) 0.009*
II 28 20(71.4)
III 47 35(74.5)
IV 8 7(87.5)
Who grading
Grade 1 14 14(100) 0.029*
Grade 2 68 50(73.5)
Grade 3 10 7(70.0)
Tumor thrombus
Negative 79 60(75.9) 0.046*
Positive 13 11(84.6)

Statistical analysis indicated that Rictor expression was correlated with tumor size, depth of invasion, lymph node metastasis, TNM stage, WHO grading and tumor thrombus. There was no significant association with gender, age, tumor location and distant metastasis. *P < 0.05.